Company profile
X4 Pharmaceuticals
Enabling a better future for people with rare immune disorders
- Industry
- Biotechnology Research
- Employees
- 80
- Headquarters
- Boston, Massachusetts
- Founded
- 2014
- LinkedIn followers
- 14,045
- Office locations
- 1
X4 Pharmaceuticals company summary
X4 Pharmaceuticals is a company in the Biotechnology Research industry, headquartered in Boston, Massachusetts, founded in 2014. On LinkedIn the company has around 80 employees and 14,045 followers. Its listed specialties include Rare disease and primary immunodeficiencies.
What technology does X4 Pharmaceuticals use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About X4 Pharmaceuticals
We are a fully integrated, commercial-stage biopharmaceutical company driving progress for people living with rare immune disorders. We listen to people whose challenges have been long overlooked, understand their needs, and develop solutions to their most urgent and critical health concerns. Our FDA-approved medication XOLREMDI® (mavorixafor) is commercially available in the U.S. in its first indication. We are evaluating mavorixafor in additional potential indications, and have an ongoing global, pivotal Phase 3 clinical trial for its use in chronic neutropenia. Our corporate headquarters is in Boston, Massachusetts.
Specialties
Where is X4 Pharmaceuticals located?
X4 Pharmaceuticals lists 1 location.
Compare companies similar to X4 Pharmaceuticals
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
X4 Pharmaceuticals x4pharma.com | Biotechnology Research | 80 | 2014 | Boston, Massachusetts |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about X4 Pharmaceuticals
What does X4 Pharmaceuticals do?
We are a fully integrated, commercial-stage biopharmaceutical company driving progress for people living with rare immune disorders. We listen to people whose challenges have been long overlooked, understand their needs, and develop solutions to their most urgent and critical health concerns. Our FDA-approved medication XOLREMDI® (mavorixafor) is commercially available in the U.S. in its first indication. We are evaluating mavorixafor in additional potential indications, and have an ongoing global, pivotal Phase 3 clinical trial for its use in chronic neutropenia. Our corporate headquarters is in Boston, Massachusetts.
How many employees does X4 Pharmaceuticals have?
X4 Pharmaceuticals has around 80 employees on LinkedIn.
Where is X4 Pharmaceuticals headquartered?
X4 Pharmaceuticals is headquartered in Boston, Massachusetts.
When was X4 Pharmaceuticals founded?
X4 Pharmaceuticals was founded in 2014.
Build a lead list from companies like X4 Pharmaceuticals
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.